Yanhong Chen

Yanhong Chen

Auto-generated profile, based on publicly available information

Yanhong Chen

Department of Pediatric Intensive Care, Binzhou People's Hospital, Binzhou, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
XWXin Wang
Xin Wang
YCYanhong Chen
Yanhong Chen
LDLili Du
Lili Du
XLXiaomei Li
Xiaomei Li
XLXiuying Li
Xiuying Li
DCDunjin Chen
Dunjin Chen
Increasing evidence has indicated that circulating placental RNAs may reflect the pathophysiology of the placenta. In the current study, circulating placenta-related long noncoding RNAs (lncRNAs) were evaluated as potential biomarkers for preeclampsia (PE). Two parts of the case‑control study were simultaneously executed, including the following sets: 52 patients with late‑onset PE (LOPE) (diagnosed after 34 weeks) and 52 gestational age (GA)‑matched controls; 58 patients with early‑onset PE (EOPE) (diagnosed before 34 weeks) and 58 GA‑matched controls. LncRNA expression was detected in the placenta analysis part, and the participants were delivered by caesarean sections. The levels of circulating placenta-associated lncRNAs were measured in the plasma analysis part and all pregnant women were included. Using microarray analysis, 163 differentially expressed lncRNAs were identified in placental samples from patients with LOPE, some of which were also detected in plasma samples from pregnant women. There were significant positive correlations between plasma, and placental expression levels of NONHSAT116812 and NONHSAT145880, which in plasma provided high diagnostic efficiencies for LOPE and EOPE. The present study demonstrated that circulating placenta‑associated lncRNAs, paticularly NONHSAT116812 and NONHSAT145880 have potential as biomarkers for PE.

1 August 2020 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
ZLZhongying Li
Zhongying Li
YCYanhong Chen
Yanhong Chen
WLWenrong Li
Wenrong Li
FYFan Yan
Fan Yan
Purpose: Hyperoxia-induced bronchopulmonary dysplasia (BPD) is a lung disease in preterm infants. We aimed to explore the role of cell division cycle 2 (CDC2) on histopathologic changes of lung tissues, as well as the viability, apoptosis, and inflammation of lung cells in rats with hyperoxia-induced BPD. Materials and Methods: Hypermda-induced BPD in neonatal rats and hyperoxia-induced A549 cells were constructed. The mRNA expression of CDC2 was detected by qRT-PCR. The fibrosis score of lung tissues was evaluated by hematoxylin-eosin staining. The viability and apoptosis of A549 cells were detected by cell counting kit-8 assay and flow cytometry. The protein expressions of bcl-2, bax, and caspase-3 were measured by western blot. The levels of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, and IL-1 beta in A549 cells were detected by enzyme-linked immunosorbent assay. The pcDNA3.1-CDC2 was injected into rats to determine the role of CDC2 in hyperoxia-induced BPD in vivo. Results: The expression of CDC2 was decreased in lung tissues of neonatal rats with hyperoxia-induced BPD and hyperoxia-induced A549 cells. The fibrosis score was increased in the lung tissues of neonatal rats with hyperoxia-induced BPD. Overexpression of CDC2 increased the viability and protein expression of bcl-2; and inhibited the apoptosis, inflammation, and protein expression of bax and dispase-3 in hyperoxia-induced A549 cells. Up -regulation of CDC2 alleviated the histopathologic changes in lung tissues of neonatal rats with hyperoxia-induced BPD. Conclusion: Overexpression of CDC2 promoted the viability and inhibited the apoptosis and inflammation of hyperoxia-induced cells, and alleviated the histopathologic changes of lung tissues in neonatal rats with hyperoxia-induced BPD.